PTH vs. PBE ETF Comparison

Comparison of Invesco DWA Healthcare Momentum ETF (PTH) to PowerShares Dynamic Biotech & Genome (PBE)
PTH

Invesco DWA Healthcare Momentum ETF

PTH Description

The PowerShares Dynamic Healthcare Sector Portfolio (Fund) is based on the Dynamic Healthcare Sector IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index thoroughly evaluates companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 60 US health care companies. These are companies that are principally engaged in the business of providing health care-related products and services, including biotechnology, pharmaceuticals, medical technology and supplies, and facilities. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$153.58

Average Daily Volume

72,400

Number of Holdings *

52

* may have additional holdings in another (foreign) market
PBE

PowerShares Dynamic Biotech & Genome

PBE Description The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Grade (RS Rating)

Last Trade

$75.54

Average Daily Volume

8,623

Number of Holdings *

30

* may have additional holdings in another (foreign) market
Performance
PTH PBE
30 Days -6.49% 0.92%
60 Days -18.40% -7.89%
90 Days -12.93% -0.79%
12 Months 66.24% 54.09%
5 Overlapping Holdings
Grade Symbol Weight in PTH Weight in PBE Overlap
C CTLT 2.4% 4.86% 2.4%
D FLGT 3.98% 2.3% 2.3%
D MYGN 1.28% 2.61% 1.28%
B TECH 1.53% 5.64% 1.53%
B VCEL 2.47% 3.48% 2.47%
PTH Overweight 47 Positions Relative to PBE
Grade Symbol Weight
F BNGO 4.53%
B HZNP 4.3%
C IDXX 3.68%
B SEEL 3.33%
C ACRS 3.26%
B CRIS 2.8%
B TXG 2.56%
A CRL 2.49%
B ALGN 2.4%
D AVXL 2.38%
B OMI 2.3%
C BCRX 2.26%
A MTD 2.26%
B MEDP 2.11%
B A 2.03%
D NVAX 1.84%
D CYH 1.79%
C ENSG 1.79%
F VERU 1.74%
A ACHC 1.72%
A ATRC 1.6%
C THC 1.57%
D ITCI 1.57%
D XLRN 1.56%
B OMCL 1.55%
B AXNX 1.44%
C NARI 1.39%
F CDXC 1.36%
B BRKR 1.34%
C MD 1.3%
D GKOS 1.28%
B SEM 1.26%
C SGRY 1.26%
C PDCO 1.22%
D TMDX 1.2%
B ORGO 1.16%
D TVTY 1.13%
D ONCT 1.08%
B BKD 1.04%
B ATEC 1.01%
D EOLS 0.98%
D CLDX 0.96%
B INOV 0.95%
B EVH 0.93%
D HSKA 0.89%
B PRTA 0.87%
F SRRK 0.52%
PTH Underweight 25 Positions Relative to PBE
Grade Symbol Weight
B AMGN -5.51%
C QGEN -5.19%
B ALXN -5.11%
F SGEN -4.89%
F BMRN -4.86%
D ILMN -4.6%
B FPRX -4.55%
C NTLA -3.52%
B UTHR -3.29%
B IRWD -3.17%
D PACB -2.98%
F SGMO -2.79%
D ALKS -2.71%
D BPMC -2.71%
F OPK -2.68%
B DRNA -2.59%
C CDNA -2.55%
D VCYT -2.52%
C HALO -2.47%
D XNCR -2.47%
D PGEN -2.36%
F EBS -2.24%
D ARWR -2.15%
D MNKD -2.13%
F FGEN -1.05%
Compare ETFs